Inflammatory Bowel Disease: Diagnosis and TreatmentGary L. Gitnick |
From inside the book
Results 1-3 of 12
Page 49
... molecules that has been reported on epithelial cells overlying active lesions in inflammatory bowel disease . The ... Molecular genetic analysis of immunoglobulin and T - cell receptor genes has shown that the lymphocyte population is ...
... molecules that has been reported on epithelial cells overlying active lesions in inflammatory bowel disease . The ... Molecular genetic analysis of immunoglobulin and T - cell receptor genes has shown that the lymphocyte population is ...
Page 282
... molecule distinct from sulfa- pyridine . Despite the concept of targeted delivery of 5 - ASA to specific sites along ... molecules of 5 - ASA released into colon Sustained - Release Preparations Pentasa capsules or tablets are composed ...
... molecule distinct from sulfa- pyridine . Despite the concept of targeted delivery of 5 - ASA to specific sites along ... molecules of 5 - ASA released into colon Sustained - Release Preparations Pentasa capsules or tablets are composed ...
Page 283
... molecules of 5 - ASA attached by the same azo bond as in sulfasalazine.34 Therefore , each 250 - mg capsule provides two molecules of 5 - ASA into the colon . Breakdown of the olsalazine dimer requires bacterial azoreductase activity ...
... molecules of 5 - ASA attached by the same azo bond as in sulfasalazine.34 Therefore , each 250 - mg capsule provides two molecules of 5 - ASA into the colon . Breakdown of the olsalazine dimer requires bacterial azoreductase activity ...
Contents
Approaches to Management | 3 |
Epidemiology | 23 |
Where Have We Been? Where Are We Going? | 29 |
Copyright | |
32 other sections not shown
Other editions - View all
Common terms and phrases
5-aminosalicylic acid abdominal abnormalities abscess acute anal anastomosis ankylosing spondylitis antibiotics antigens arthritis associated azathioprine barium biopsies cancer carcinoma cells chronic clinical colectomy colitis and Crohn's colon colonoscopy complications controlled trial corticosteroids Crohn's colitis Crohn's disease diagnosis diarrhea diet dilatation disease activity disease and ulcerative distal dosage dose drug dysplasia endoscopic enemas epithelial evaluation factors fistulas Gastroenterology genetic histologic hydrocortisone IBD patients ileal ileoanal ileostomy ileum immunosuppressive improved increased inflammation inflammatory bowel disease intestinal intravenous involvement Lancet Lennard-Jones lesions manifestations methotrexate metronidazole mucosa normal obstruction occur oral parenteral nutrition patients with Crohn's patients with ulcerative perianal physician placebo pouch procedure prednisolone prednisone present proctitis prognosis rectal rectum recurrence relapse remission reported resection response risk serum side effects sigmoidoscopic small bowel steroids stool strictures sulfasalazine Surg surgery surgical symptoms therapeutic therapy tion tissue toxic megacolon treated Truelove ulcerative colitis usually